search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

[Childhood cancer after fertility treatments?].

Mandy Spaan ,
C B Nils Lambalk ,
Floor E van Leeuwen

Abstract

Since the introduction of Assisted Reproductive Technology (ART) in 1978, more than 10 million ART-conceived children have been born. Each phase of the ART procedure is substantially different from natural conception and these processes occur in the same timeframe as epigenetic programming. It seems plausible that ART could influence early stages of embryogenesis and thereby permanently influence the development and health of these individuals. Several epidemiological studies investigated the risk of childhood cancer after ART. Overall, results appear reassuring and do not indicate an increased risk. However, for subgroups, including children born after frozen-thawed embryo transfer(FET) there might be a modestly increased risk. There are some biological explanations for an increased risk of cancer after FET. However, as results are based on a small number of cancer cases, results must be replicated in other large cohort studies before translation into clinical practice.

More about this publication

Nederlands tijdschrift voor geneeskunde

Volume 167
Publication date 28-11-2023

Full text links

Publisher website (DOI) 38175562
Europe PubMed Central 38175562

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.